About Shree Anand Life Sciences
Shree Anand Life Sciences is a Healthcare company based in Belgaum (India) founded in 2006. Manufacturing of pharmaceutical injections and healthcare products in India. The company has 156 employees. Its Indian entity Shree Anand Life Sciences Limited reported revenue of ₹40.42 Cr. Shree Anand Life Sciences offers products and services including Liquid Injections and Lyophilized Injections. Its focus areas include Pharmaceuticals, Drug Manufacturing, Injections Production and Life Sciences.
Company details
Shree Anand Life Sciences Ltd is derived from partnerships in Anand Pharmaceuticals, which has operated in the pharmaceutical sector since 1989. It is involved in the development and production of various injections, such as liquid, lyophilized, dry powdered, and pre-filled types, to treat a wide range of diseases. Quality is maintained through adherence to stringent specifications and continuous improvements in processes, ensuring products meet global standards for purity and efficiency to serve export and domestic markets effectively.
- Headquarters Belgaum, India
- Employees 156
- SectorsHealthcare
- Email••••••••
- Website salsl.com
- Social LinkedIn
- Legal Name Shree Anand Life Sciences Limited
- Date of Incorporation 06 Nov, 2006
- Jurisdiction Belgaum, Karnataka, India
- Annual Revenue₹40.42 Cr
FY 2023 · -2% YoY
- Net Loss-₹29.75 Cr
FY 2023 · -74% margin
- EBITDA-₹62.8 Lakh
FY 2023 · -2% margin
- Employee Count156
Associated legal entities of Shree Anand Life Sciences
Shree Anand Life Sciences operates through Shree Anand Life Sciences Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Shree Anand Life Sciences Limited CIN U24232KA2006PLC040855 | Active | 06 Nov 2006 | Belgaum, Karnataka | ₹40.4 Cr | 156 | 6 | View details |
Products & Services of Shree Anand Life Sciences
Shree Anand Life Sciences offers a comprehensive portfolio of products and services, including Liquid Injections and Lyophilized Injections.
Liquid injections, including ampoules, vials, and pre-filled syringes, are produced for treating diseases
Lyophilized injections are manufactured for enhanced stability in medical applications
Board of directors of Shree Anand Life Sciences Limited (Shree Anand Life Sciences)
Shree Anand Life Sciences Limited is the primary company behind Shree Anand Life Sciences. The board of Shree Anand Life Sciences Limited currently have 5 directors; the longest-serving is Satish Mohanrao Gharge, appointed in 2006. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Satish Mohanrao Gharge DIN 02443705 | Managing Director | 06 Nov 2006 | 20 yrs | Shree Anand Life Sciences Limited |
| Sanjay Mohanrao Gharge DIN 02443851 | Director | 06 Nov 2006 | 20 yrs | Shree Anand Life Sciences Limited |
| Gharge Asha Satish DIN 02454739 | Director | 06 Nov 2006 | 20 yrs | Shree Anand Life Sciences Limited |
| Virendra Shashikant Pawar DIN 08046855 | Director | 09 Sep 2015 | 11 yrs 1 mo | Shree Anand Life Sciences Limited |
| Aishwarya Satish Gharge DIN 08045713 | Director | 12 Mar 2018 | 8 yrs 7 mo | Shree Anand Life Sciences Limited |
Financials of Shree Anand Life Sciences
Figures of Shree Anand Life Sciences Limited, the primary company behind Shree Anand Life Sciences, for FY 2023. Revenue was ₹40.42 Cr (-2% year on year). Net loss was -₹29.75 Cr (-74% margin). EBITDA was -₹62.8 Lakh (-2% margin). Revenue has grown at a compounded annual rate of +104% over three years and +267% over five years.
- ₹40.42 CrRevenue · FY 2023 · -2% YoY
- -₹29.75 CrNet loss · -74% margin
- -₹62.8 LakhEBITDA · -2% margin
- ₹14.61 CrPaid-up capital
- 156Employees (provident fund records)
- +104%Revenue CAGR, 3 years
- +267%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Shree Anand Life Sciences Limited are on its company page.
Detailed financial statements for Shree Anand Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Shree Anand Life Sciences
Shree Anand Life Sciences was founded in 2006.
Shree Anand Life Sciences is headquartered in Belgaum, India. It is registered at Belgaum, Karnataka, India.
Shree Anand Life Sciences has 156 employees.
The primary company behind Shree Anand Life Sciences, Shree Anand Life Sciences Limited, reported revenue of ₹40.42 Cr for FY 2023, down 2% year on year.
Shree Anand Life Sciences Ltd is derived from partnerships in Anand Pharmaceuticals, which has operated in the pharmaceutical sector since 1989. It is involved in the development and production of various injections, such as liquid, lyophilized, dry powdered, and pre-filled types, to treat a wide range of diseases. Quality is maintained through adherence to stringent specifications and continuous improvements in processes, ensuring products meet global standards for purity and efficiency to serve export and domestic markets effectively.
Shree Anand Life Sciences offers Liquid Injections and Lyophilized Injections.
Shree Anand Life Sciences operates through Shree Anand Life Sciences Limited.
The legal entities of Shree Anand Life Sciences currently have 6 directors, including Satish Mohanrao Gharge, Sanjay Mohanrao Gharge, Gharge Asha Satish and others.